61.
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
by Wilk, Aaron J
Nature medicine, 2020-07, Vol.26 (7), p.1070-1076
62.
Cellular immune correlates of protection against symptomatic pandemic influenza
by Sridhar, Saranya
Nature medicine, 2013-10, Vol.19 (10), p.1305-1312
63.
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
by Xing, Weijia, PhD
The Lancet infectious diseases, 2014, Vol.14 (4), p.308-318
64.
Definition and classification of cancer cachexia: an international consensus
by Fearon, Kenneth, Prof
The lancet oncology, 2011, Vol.12 (5), p.489-495
65.
Systemic lupus erythematosus
by Lisnevskaia, Larissa, MD
The Lancet (British edition), 2014, Vol.384 (9957), p.1878-1888
66.
Individualised exercise improves endothelial function in patients with rheumatoid arthritis
by Metsios, George S
Annals of the rheumatic diseases, 2014-04, Vol.73 (4), p.748-751
67.
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
by Bachert, Claus
Journal of allergy and clinical immunology, 2017-10, Vol.140 (4), p.1024-1031.e14
68.
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
by Iadecola, Costantino
Hypertension (Dallas, Tex. 1979), 2016-12, Vol.68 (6), p.e67-e94
69.
Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy
by Gomez-Arango, Luisa F
Hypertension (Dallas, Tex. 1979), 2016-10, Vol.68 (4), p.974-981
70.
Heart failure
by Metra, Marco, MD
The Lancet (British edition), 2017, Vol.390 (10106), p.1981-1995
71.
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase...
by Feagan, Brian G, Prof
The Lancet (British edition), 2017, Vol.389 (10080), p.1699-1709
72.
Pathological narcissism and narcissistic personality disorder
by Pincus, Aaron L
Annual review of clinical psychology, 2010, Vol.6 (1), p.421-446
73.
Standardizing ADOS Domain Scores: Separating Severity of Social Affect and Restricted and Repetitive Behaviors
by Hus, Vanessa
Journal of autism and developmental disorders, 2012-11-11, Vol.44 (10), p.2400-2412
74.
Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
by Salvi, Mario
The journal of clinical endocrinology and metabolism, 2015-02, Vol.100 (2), p.422-431
75.
Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis
by Moore, Wendy C., MD
Journal of allergy and clinical immunology, 2013, Vol.133 (6), p.1557-1563.e5
76.
The airway microbiome in patients with severe asthma: Associations with disease features and severity
by Huang, Yvonne J., MD
Journal of allergy and clinical immunology, 2015, Vol.136 (4), p.874-884
77.
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
by Hanley, Daniel F, Prof
The Lancet (British edition), 2017, Vol.389 (10069), p.603-611
78.
Congenital adrenal hyperplasia
by El-Maouche, Diala, MD
The Lancet (British edition), 2017, Vol.390 (10108), p.2194-2210
79.
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and trea...
by Lawitz, Eric, Prof
The Lancet (British edition), 2014, Vol.384 (9956), p.1756-1765
80.
Meta-analysis of prevalence
by Barendregt, Jan J
Journal of epidemiology and community health (1979), 2013-11, Vol.67 (11), p.974-978
